Percivia LLC
Office phone +1 617-301-****
Get Phone Number
Homepage http://www.percivia.com
LinkedIn Profile https://linkedin.com/company/pe***ivi***
HQ Location
United States , Massachusetts, Cambridge:1 Hampshire St, Cambridge, MA 02139
PERCIVIA is a venture formed by Crucell N.V. and Royal DSM N.V., to develop recombinant therapeutic proteins using the PER.C6® human cell line, with a focus on biosimilar monoclonal antibodies globally. Additionally, PERCIVIA out-licenses the PER.C6® cell line and provides logistical support by training and advising on the methods of recombinant protein production using the technology to licensees.
PERCIVIA’s unique advantage lies in the core technologies of PER.C6®, the company’s high yield proprietary human cell line, which enables SCALE™, a market-optimized manufacturing process, allowing for rapid facility set up with an “In Market, For Market”™ manufacturing solution.
Biotechnology and Molecular Biology Research
Companies in the biotechnology and molecular biology industry use advanced technologies to research and develop products that are used to diagnose or treat diseases. This also involves gene manipulation which can be used to create new medicines or vaccines.
Career Opportunities at Percivia LLC
Stay updated on the latest job openings by checking back regularly or by visiting the company's official career page.
No job listings currently found.
Employees of 'Percivia LLC'
Decision makers at Percivia
2 Decision Makers at Percivia
Purchasing & operations at Percivia
2 Purchasing & Operations at Percivia
Information technology at Percivia
1 Information Technology at Percivia
Details of Percivia
Related Companies and Competitors
Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.
